Tools and technologies enabling healthcare

Cambridge, GB · 1 known investors

Cambridge Nucleomics develops a platform for rapid, single-molecule detection of high-plex RNA biomarkers, enabling clinical diagnostics in approximately one hour. The technology serves clinical decision-making in time-critical healthcare applications.